It is getting pretty thin in analyst coverage as we get closer to Labor Day, but these are the upgrades and downgrades we are seeing this Wednesday morning:
Exponent (EXPO) Started as Buy at SunTrust.
eHealth (EHTH) Started as Buy at Merriman Curhan Ford.
Incyte (INCY) Started as Buy at Citigroup.
Rigel (RIGL) Started as Buy at Citigroup.
Wimm-Bill-Dann Foods (WBD) Raised to Buy at UBS.
AMR (AMR) Cut to Sell at Citigroup.
Amylin Pharma (AMLN) Cut to Neutral at Baird.
BankUnited (BKUNA) Cut To Sell at Stifel Nicolaus.
National Grid (NGG) Cut to Equal Weight at Lehman.
Jon C. Ogg August 27, 2008
“The Next NVIDIA” Could Change Your Life
NVIDIA has returned 250-fold in the past 10 years as artificial intelligence took off.
But if you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over.
The 24/7 Wall Street Analyst who first called NVIDIA’s AI-fueled rise in 2009 just published a brand-new research report named “The Next NVIDIA.”
The report outlines key breakthroughs in AI and the stocks ready to dominate the next wave of growth. The report is absolutely free. Simply enter your email below
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.